Company: TVRD
Filing Date: 2025-02-14
Form Type: S-4/A
Source: 0001104659-25-013053
Chunk: 1195

Company: Tvardi Therapeutics, Inc.
Filing Date: 2025-02-14
Form: S-4/A
Chunk 1195
---
 ​ |                        |   | ​ |                 |   |
| 101.CAL       | ​ | ​ | Inline XBRL Taxonomy Extension Calculation Linkbase Document                                                                                                                                      | ​ | ​ |                           |   | ​ |      |   | ​ |        |   | ​ |               |   | ​ |                        |   | ​ |                 |   |
| 101.DEF       | ​ | ​ | Inline XBRL Taxonomy Extension Definition Linkbase Document                                                                                                                                       | ​ | ​ |                           |   | ​ |      |   | ​ |        |   | ​ |               |   | ​ |                        |   | ​ |                 |   |
| 101.LAB       | ​ | ​ | Inline XBRL Taxonomy Extension Label Linkbase Document                                                                                                                                            | ​ | ​ |                           |   | ​ |      |   | ​ |        |   | ​ |               |   | ​ |                        |   | ​ |                 |   |
| 101.PRE       | ​ | ​ | Inline XBRL Taxonomy Presentation Linkbase Document                                                                                                                                               | ​ | ​ |                           |   | ​ |      |   | ​ |        |   | ​ |               |   | ​ |                        |   | ​ |                 |   |
| 107           | ​ | ​ | Filing Fee Table                                                                                                                                                                                  | ​ | ​ | ​                         | ​ | ​ | ​    | ​ | ​ | ​      | ​ | ​ | X             | ​ | ​ | ​                      | ​ | ​ | ​               | ​ |

# Management contracts or compensatory plans or arrangements. * Confidential treatment has been granted with respect to certain portions of this exhibit. Omitted portions have been filed separately with the Securities and Exchange Commission. † Certain portions of this exhibit (indicated by asterisks) have been omitted because they are not material and is the type of information that the Company treats as private or confidential.
II-8

TABLE OF CONTENTS

**(b)**

### Financial Statement Schedules
Not Applicable.

**(d)**

#### Filing Fee
See Exhibit 107.

<div align='center'>II-9</div>

TABLE OF CONTENTS

## Item 22 — Undertakings
(a)

The undersigned registrant hereby undertakes as follows:

(1)

To file, during any period in which offers or sales are being made, a post-effective amendment to this registration statement:

(i)

to include any prospectus required by Section